Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background: Benzodiazepine (BZD), the long-term treatment of which is harmful for cognitive function, is widely prescribed by General Practitioners in Spain. Based on studies performed in other countries we designed a nurse-led BZD withdrawal program adapted to Spanish Primary Care working conditions. Results: A pseudo-experimental (before-after) study took place in two Primary Care Centres in Barcelona. From a sample of 1150 patients, 79 were identified. They were over 44 years old and had been daily users of BZD for a period exceeding six months. Out of the target group 51 patients agreed to participate. BZD dosage was reduced every 2-4 weeks by 25% of the initial dose with the optional support of Hydroxyzine or Valerian. The rating measurements were: reduction of BZD prescription, demographic variables, the Short-Form Health Survey (SF-12) to measure quality of life, the Medical Outcomes Study (MOS) Sleep Scale, and the Goldberg Depression and Anxiety Scale. By the end of the six-month intervention, 80.4% of the patients had discontinued BZD and 64% maintained abstinence at one year. An improvement in all parameters of the Goldberg scale (p <0.05) and in the mental component of SF-12 at 3.3 points (p = 0.024), as well as in most components of the MOS scale, was observed in the group that had discontinued BZD. No significant differences in these scales before and after the intervention were observed in the group that had not discontinued. Conclusions: At one year approximately 2/3 of the patients had ceased taking BZD. They showed an overall improvement in depression and anxiety scales, and in the mental component of the quality of life scale. There was no apparent reduction in the sleep quality indicators in most of the analysed components. Nurses in a Primary Care setting can successfully implement a BZD withdrawal program.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos
Vilagut, G., Ferrer, M., Rajmil, L., Rebollo, P., Permanyer-Miralda, G., Quintana, J. M., Santed, R., Valderas, J. M., Ribera, A., Domingo-Salvany, A., et al. (2005) · Gaceta Sanitaria · doi:10.1157/13074369 · Cited by 831
Morin, C. M., Bastien, C., Guay, B., Radouco-Thomas, M., Leblanc, J., & Vallières, A. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.332 · Cited by 348 · cited 1×
“Although cognitive behavioural therapy is an effective adjuvant therapy in BZD withdrawal programs [19,20] its implementation in daily practice can have significant cost and time implications.”
BackgroundWithdrawing Benzodiazepines in Primary Care
Lader, M., Tylee, A., & Donoghue, J. (2009) · CNS Drugs · doi:10.2165/0023210-200923010-00002 · Cited by 318 · cited 1×
“More than twenty years ago it was reported that the benefit of BZD was significantly reduced after fifteen days of use [27].”
BackgroundStrategies for discontinuing long-term benzodiazepine use: Meta-analysis
Voshaar, R. C. O., Couvée, J. E., Van Balkom, A. J. L. M., Mulder, P. G. H., & Zitman, F. G. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.189.3.213 · Cited by 205 · cited 1×
“7% success rate (percentage of BZD cessation cases maintained for one year) shows that, after specific training, nurses in a Primary Care setting can implement a program with the objective of achieving the cessation of BZD intake in volunteer patients, with similar results to studies conducted by other professionals s…”
CURRAN, H. V., COLLINS, R., FLETCHER, S., KEE, S. C. Y., WOODS, B., & ILIFFE, S. (2003) · Psychological Medicine · doi:10.1017/s0033291703008213 · Cited by 190 · cited 7×
“This finding helped to confirm that the consumption of a higher dose of BZD does not improve sleep quality [7,28].”
BackgroundMethodResultInfluentialFourrier, A., Letenneur, L., Dartigues, J., Moore, N., & Bégaud, B. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100326 · Cited by 158 · cited 1×
“This highlights non-compliance with national guidelines based on previous studies [26] which advise limiting the use of BZD to the onset of SSRI treatment.”
MethodThe treatment of benzodiazepine dependence
ASHTON, H. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03755.x · Cited by 110
O'Connor, K. P., Marchand, A., Bélanger, L., Mainguy, N., Landry, P., Savard, P., Turcotte, J., Dupuis, G., Harel, F., & Lachance, L. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.01.001 · Cited by 44 · cited 1×
“Their socio-demographic features matched those of patients defined as being at risk of chronic BZD use [24,25].”
BackgroundThe natural history of tolerance to the benzodiazepines
Higgitt, A., Fonagy, P., & Lader, M. (1988) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000412 · Cited by 37 · cited 1×
“Nevertheless, it must be conceded that our outcome could be partly attributed to an inaccurate diagnosis of insomnia, mistaking this, and the patient’s addiction due to tolerance [32], for physiological sleep disturbances related to age, which are easy to treat through advice and sleep hygiene.”
BackgroundPsychological Distress and Adaptational Problems Associated with Discontinuation of Benzodiazepines
O’Connor, K., Bélanger, L., Marchand, A., Dupuis, G., Elie, R., & Boyer, R. (1999) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00107-5 · Cited by 29 · cited 1×
“Their socio-demographic features matched those of patients defined as being at risk of chronic BZD use [24,25].”
Background
Cited by
Reeve, E., Ong, M., Wu, A., Jansen, J., Petrovic, M., & Gnjidic, D. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2257-8 · Cited by 192
Ng, B. J., Le Couteur, D. G., & Hilmer, S. N. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0544-4 · Cited by 118
“The feasibility of supervised GDR is shown in cohort studies of community-dwelling patients, as summarised in Table 2 [90, 94].”
MethodDeprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
Pollmann, A. S., Murphy, A. L., Bergman, J. C., & Gardner, D. M. (2015) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-015-0019-8 · Cited by 114
“Clinical outcomes such as impact on reducing falls, fractures, quality of life, and mortality have been evaluated less frequently [108, 198].”
BackgroundFluyau, D., Revadigar, N., & Manobianco, B. E. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317753340 · Cited by 109
A review of the management of antidepressant discontinuation symptoms
Wilson, E., & Lader, M. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315612334 · Cited by 103
Metadata
- Authors
- Lopez-Peig, C., Mundet, X., Casabella, B., del Val, J. L., Lacasta, D., & Diogene, E.
- Venue
- BMC Research Notes
- Published
- 2012-12
- Volume
- 5
- Issue
- 1
- Pages
- 684-684
- ISSN
- 1756-0500 (ISSN-L)
- OpenAlex
- W2089760796
- Cited by
- 25
- References
- 10
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain. https://app.cochat.ai/papers/10.1186/1756-0500-5-684
- The paper
- Lopez-Peig, C., Mundet, X., Casabella, B., del Val, J. L., Lacasta, D., & Diogene, E. (2012). Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain. BMC Research Notes. https://doi.org/10.1186/1756-0500-5-684
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.